We inform you that our offices will be closed from August 4th to 19th inclusive.

For urgencies, contact the following numbers:

Sara Conotter 329 675 24 50 (professionals)
Sofia Dallago 391 748 63 68 (private)

Thank you!



Seqex is a patented medical device for the treatment of disorders and diseases of the muscular and skeletal system.
It exploits the beneficial effects of electromagnetic fields, generated at extremely low intensities and frequencies, administered in customized pulsed cycles both over the entire body and locally.

The name SEQEX comes from the union of two terms of the ancient Andean language: SEQE means direction or polarity, and X stands for the meeting between electromagnetic and magnetoelectric energy.

The first Seqex prototype was developed in 1996, based on the discovery of the ICR-like phenomenon by the American biophysicist Abraham Liboff and with the help of some skilled researchers in physics, medicine, and biology, creating an innovative new technology for the emission of therapeutic electromagnetic fields.
In 1999 the company SISTEMI was founded for the manufacture and marketing of Seqex in Italy.
In 2017 the marketing program went international, starting with Canada.

All the Seqex models are approved under Directive 92/43 CE as medical devices, and designed for therapeutic treatment commonly known as “magnetotherapy” using variable electromagnetic fields applied to the whole body and, when necessary, also locally. However, Seqex differs greatly from the other widely available magnetotherapy systems thanks to a combination of certain design and technological features: firstly the use of extremely low frequency fields (from 1 to 80 Hz), intensities below 20 µT (0.2 Gauss), the generation of 30 different waveforms, and above all the customization of treatment using a patented test procedure.

The other widely available magnetotherapy devices on the market produce digital electromagnetic signals consisting of waveform, intensity, and frequency combinations referred to as “codes” or protocols. These devices administer the same identical sequence of codes (generally a few dozen) to all patients with the same pathology.
Seqex instead is capable of producing more than 2 million of these codes, requiring computerized management. During the test procedure, the sequence of codes is customized on the basis of the measured response of the patient’s body. In addition, the 30 waveforms generated by Seqex are “constructed” as analog signals to ensure “harmonic complexity”, unlike the smooth “digital” signals produced by almost all the other available devices.

The exclusivity of Seqex derives from the customization test, conducted at a Seqex center by authorized medical personnel, using a professional Seqex Med device.

The use of SEQEX devices for therapeutic purposes must be under qualified medical supervision.

The professional model reserved for doctors and physiotherapists is called the Seqex Med. It conducts an initial customization test in which the electromagnetic field is generated and modulated by the device in 30 waveforms, transmitted at precise frequencies and intensities from a mat. The patient lies, dressed normally on the mat while electrodes applied to the hands and feet measure the bio-electric variations that occur in response to the stimulation of the field emitted by the mat. The test establishes a sequence of field frequencies and intensities combined with the 9 most efficient waveforms derived from the therapeutic program selected by the medical professional on the basis of the bio-physical characteristics of the person being treated. This sequence is saved on a memory-CARD as a customized treatment program that can be administered either at clinics using the professional device (Seqex Med), or in the comfort of your own home with one of the program card reader devices designed for family and home use (Seqex Fam and Seqex HC). Card customization is conducted at a Seqex treatment center.

Seqex Med can be used both for customization tests and administering electromagnetic treatment, which can be total body or on localized areas (using various accessories, including a hand probe or intensive pad). 

The main field of application for electromagnetic therapy is to treat osteoarticular and musculotendinous disorders.
Seqex signals are very rich in “harmonics” and so more easily enter into “resonance” with the numerous elements comprising the cells of the human organism.
For this reason, in addition to the traditional magnetotherapy applications on the musculoskeletal apparatus, Seqex is also included in numerous integrative medicine protocols with the purpose of: reducing healing time, reducing pain, restoring cellular metabolic equilibrium, improving general wellness and quality of life. Seqex is increasingly used as an adjuvant to traditional clinical treatments.

Many studies have demonstrated that calibrated electromagnetic stimuli can help to normalize certain physiological cell functions. They can also favor a regulation of the antioxidant activity in an organism, reducing the production of free radicals and so improving the efficiency of the body and its capacity to recover from musculoskeletal sports injuries.

Seqex devices therefore support the work of physiotherapists during traditional courses of rehabilitation.

Treatment must NOT be administered in cases of: pregnancy, heart disease, epilepsy, presence of heart stimulators (pacemakers), haemorrhage, neoplasia, or transplants.

In reply to a specific application for assessment submitted by S.I.S.T.E.M.I. srl, the Italian Revenue Agency, Provincial Directorate of Trento, concluded that the payment of expenses for the purchase or rent of SEQEX brand electromedical equipment can be considered in all effects a “medical expense” with entitlement to deduction from personal income tax to the extent of 19% (pursuant to art. 15, par. 1 of Italian Pres. Dec. 917/86). The deduction can be claimed during presentation of either the 730 or Unified tax forms.

Eligibility for deduction is dependent on possession of a specific medical prescription for the use of a relevant device.


Contact us to find out about this new device which can help your patients and enhance your medical practice.